Replies to post #89590 on SMART MONEY GROUP

[TheFinalCD]

looks like they only have just 1 other than EG-1962
, and seems way too soon for any immediate hope for EG-1964

The pipeline won't be bailing out shareholders any time soon. EG-1962 is being investigated in a phase 1 trial and an Investigational New Drug enabling study for treating similar injuries. A second drug candidate, EG-1964, is in preclinical trials. In other words, even if the drug candidates and approach can be proven to work, investors are looking at a very long road ahead.

https://www.fool.com/investing/2018/03/28/heres-why-edge-therapeutics-stock-collapsed-today.aspx




http://www.edgetherapeutics.com/pipeline/

Edge will assess the next steps for the company, but anticipates in the near term reducing the scope of its operations, including the size of its workforce, in order to preserve its cash resources, which were $88.1 million as of December 31, 2017.

even though they may look cash rich at the moment, it really depends on their cash burn rate, and with the EG-1962 fail, funding might not be there...

its a poke & hope at this point

could be a while before any light seen at the end of the tunnel/pipeline

imo

[TheFinalCD]

https://finviz.com/quote.ashx?t=SHLD&ty=c&ta=1&p=d